Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 69, 2005 - Issue 1
Journal homepage
177
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Adenovirus-Mediated Suicide SCLC Gene Therapy Using the Increased Activity of the hTERT Promoter by the MMRE and SV40 Enhancer

Joon-Seok SONGInstitute of Biotechnology, Korea University
Pages 56-62 | Received 04 Aug 2004, Accepted 26 Oct 2004, Published online: 22 May 2014

  • 1) Ihde, D. C., Chemotherapy of lung cancer. N. Engl. J. Med., 327, 1434–1440 (1992).
  • 2) Takahashi, T., Obata, Y., Sekido, Y., Hida, T., Ueda, R., Watanabe, H., Ariyoshi, Y., Sugiura, T., and Takahashi, T., Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res., 49, 2683–2688 (1989).
  • 3) Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazddar, F. G., Piatyszek, M. A., and Shay, J. W., Telomerase activity in small-cell and non-small-cell lung cancer. J. Natl. Cancer Inst., 87, 895–901 (1995).
  • 4) Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S., and Bacchetti, S., Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55, 2533–2536 (1995).
  • 5) Sahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T., Telomerase activity in human liver tissue: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res., 5, 2734–2736 (1995).
  • 6) Counter, C. M., Guota, J., Harley, C. B., Leber, B., and Bacchetti, S., Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 85, 2315–2320 (1995).
  • 7) Schwartz, H. S., Juliao, S. F., Sciadini, M. F., Miller, L. K., and Butler, M. G., Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer, 75, 1094–1099 (1995).
  • 8) Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., and Coffey, D. S., Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56, 218–222 (1996).
  • 9) Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W., Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88, 116–122 (1996).
  • 10) Counter, C. M., Irte, H. W., Bacchtti, S., and Harley, C. B., Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. U.S.A., 91, 2900–2904 (1994).
  • 11) Feng, J., Funk, W. D., Wang, S. S., Weinric, A. A. A., Ciu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrew, W. H., Greider, C. W., and Villeponteau, B., The RNA component of human telomerase. Science, 269, 1236–1241 (1995).
  • 12) Ito, H., Kyo, S., Kanaya, T., Takakura, M., Inoue, M., and Namiki, M., Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res., 4, 1603–1608 (1998).
  • 13) Kanaya, T., Kyo, S., Takakura, M., Ito, H., Namiki, M., and Inoue, M., hTERT is a critical determinant of telomerase activity in renal carcinoma. Int. J. Cancer, 78, 539–543 (1998).
  • 14) Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., and Inoue, M., Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res., 58, 1558–1561 (1998).
  • 15) Izumi, H. P., Louann, C., Cynthia, A., and Carl, B., Cloning and characterization of the promoter region of the human telomerase reverse transcriptase gene. Cancer Res., 59, 826–830 (1999).
  • 16) Masahiro, T., Satoru, K., Taro, K., Hisao, H., Jun, T., Masuo, Y., and Masaki, I., Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res., 59, 551–557 (1999).
  • 17) Blackwood, E. M., and Eisenman, R. N., Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 251, 1211–1217 (1991).
  • 18) Kumagai, T., Tanio, Y., Osaki, T., Hosoe, S., Tachibana, I., Ueno, K., Kijima, T., Horai, T., and Kishimoto, T., Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc–Max response elements. Cancer Res., 56, 354–358 (1996).
  • 19) Reid, R., Mar, E. C., Huang, E. S., and Topal, M. D., Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J. Biol. Chem., 263, 3898–3904 (1988).
  • 20) Beltinger, C., Fulda, S., Kammertoens, T., Meyer, E., Uckert, W., and Debatin, K. M., Herpes simplex virus thymidine kinase ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl. Acad. Sci. U.S.A., 96, 8699–8704 (1999).
  • 21) Song, J. S., Kim, H. P., Lee, K. W., Kim, M. H., Kim, K. T., Kim, H. S., and Kim, Y. T., Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line. Biosci. Biotechnol. Biochem., 67, 2344–2350 (2003).
  • 22) Song, J. S., and Kim, H. P., Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line. Oncology Reports, 12, 443–448 (2004).
  • 23) Song, J. S., Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by SV40 enhancer. Biosci. Biotechnol. Biochem., 68, 246–251 (2004).
  • 24) Becker, T. C., Noel, R. J., Coats, W. S., Gomez-Foix, A. M., Alam, T., Gerard, R. D., and Newgard, C. B., Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol., 43, 161–189 (1994).
  • 25) Graham, F. L., and Van der Eb, A. J., A new technique for the assay of infectivity of human adenovirus 5 DNA. Viology, 52, 456–467 (1973).
  • 26) Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinric, S. L., and Shay, J. W., Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011–2015 (1994).
  • 27) Schreiber, E., Matthias, P., Muller, M., and Schaffner, W., Rapid detection of octamer binding proteins with ‘mini-extracts’ prepared from a small number of cells. Nucleic Acids Res., 17, 6419 (1989).
  • 28) Barr, L. F., Campbell, S. E., Diette, G. B., Gabrielson, E. W., Kim, S., Shim, H., and Dang, C. V., c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Cancer Res., 60, 143–149 (2000).
  • 29) Komata, T., Kanzawa, T., Kondo, Y., and Kondo, S., Telomerase as a therapeutic target for malignant gliomas. Oncogene, 21, 656–663 (2002).
  • 30) Song, J. S., Kim, S. B., Lee, K. W., Jung, H. H., Kim, M. H., Kim, K. T., Brown, R., and Kim, Y. T., Adenovirus-mediated antisense expression of telomerase template RNA induces apoptosis in lung cancer cells. J. Microbiol. Biotechnol., 12, 89–95 (2002).
  • 31) Song, J. S., Kim, D. S., Lee, K. W., Kim, M. H., Kim, K. T., and Kim, Y. T., Adenovirus-mediated antisense telomerase with cisplatin increased susceptibility to cisplatin resistant ovarian cancer cell line. J. Microbiol. Biotechnol., 12, 711–715 (2002).
  • 32) Wu, K. J., Carla, G., Mario, A., Natalie, S., Axel, P., Joachim, L., and Riccardo, D. F., Direct activation of TERT transcription by c-Myc. Nature Genetics, 21, 220–224 (1999).
  • 33) Kohtaro, F., and Morinobu, T., Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-Myc mRNA. Biochem. Biophys. Res. Commun., 248, 368–371 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.